Results 211 to 220 of about 153,861 (252)
Some of the next articles are maybe not open access.

Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.

Thrombosis and haemostasis, 1995
Lupus anticoagulants are a group of antibodies commonly found in patients with autoimmune diseases such as systemic lupus erythematosus. Lupus anticoagulants inhibit phospholipid dependent coagulation and may bind to negatively charged phospholipids.
I, Schousboe, M S, Rasmussen
openaire   +2 more sources

New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies

Current Rheumatology Reports, 2014
Beta-2 glycoprotein I (β2GPI) is the main antigenic target for antiphospholipid antibodies (aPL), the serological markers of antiphospholipid syndrome (APS). Domain I (DI) of β2GPI has lately been identified as the main epitope targeted by antibodies reacting against β2GPI. DI is a cryptic epitope, becoming available for autoantibody binding when β2GPI
C.B. Chighizola, M. Gerosa, P.L. Meroni
openaire   +3 more sources

Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.

Thrombosis and haemostasis, 2003
To clarify the role(s) of anti-beta(2) GPI antibodies on thrombosis in anti-phospholipid antibody syndromes (APS), the effect of IgG from three patients on activated protein C (APC) was investigated using phospholipid vesicles and purified proteins. Two of the total IgG inhibited APC activity in the presence of beta(2)GPI, whereas the third IgG did not.
Tomonori, Izumi   +4 more
openaire   +1 more source

Clinical significance of anti-beta 2-glycoprotein I antibodies.

Annales de medecine interne, 1997
Antiphospholipid antibodies are a heterogeneous group of autoantibodies with clinical importance because of their strong association with thrombotic events. Recent evidence have shown that antiphospholipid antibodies are not directed against phospholipids, as has previously been thought, but are a part of a large family of autoantibodies against ...
O, Amengual   +3 more
openaire   +1 more source

Beta2-Glycoprotein I

Lupus, 1994
D A, Kandiah, S A, Krilis
openaire   +2 more sources

Apolipoprotein H (beta-2-glycoprotein I) polymorphism in Asians.

Human biology, 1992
Apolipoprotein H (APOH) (beta-2-glycoprotein I) polymorphism has been studied in 1159 Asians. The sample included 872 Chinese, 179 Asiatic Indians (Dravidian), 91 Filipinos, and 17 Malays. APOH polymorphism was determined by isoelectric focusing of sera in thin-layer polyacrylamide gels containing 3 M urea followed by immunoblotting. The frequencies of
Saha, N.   +4 more
openaire   +1 more source

Antibodies to beta(2)-glycoprotein I in ischemic stroke.

Cerebrovascular diseases (Basel, Switzerland), 2000
Antibodies to beta(2)-glycoprotein (beta(2)-GPI) have been associated with recurrent thrombotic events in patients with systemic lupus erythematosus. The present study investigated the prevalence of antibodies to beta(2)-GPI in an unselected group of patients with ischemic stroke.
Fiallo P   +3 more
openaire   +2 more sources

[Investigation of binding capacity of beta 2-glycoprotein I with anti-beta 2-glycoprotein I antibodies in lymphocytes undergoing apoptosis].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2000
Apoptosis (programmed cell death) is accompanied by loss of phospholipid asymmetry, i.e., translocation of aminophospholipids such as phosphatidylserine to the outer leaflet of the plasma membranes, which results in recognition of these cells by macrophages.
openaire   +1 more source

Resistance to activated protein C activity of an anti-beta 2-glycoprotein I antibody in the presence of beta 2-glycoprotein I.

British journal of haematology, 1995
Some researchers claim that lupus anticoagulant-positive plasma may cause a false-positive reaction in the test for activated protein C (APC) resistance, a hereditary thrombophilic state characterized by abnormal factor V, which frequently causes venous thrombosis.
J, Matsuda   +5 more
openaire   +1 more source

The interaction of beta 2 glycoprotein-I and heparin and its effect on beta 2 glycoprotein-I antiphospholipid antibody cofactor function in plasma.

Thrombosis and haemostasis, 1995
beta 2 glycoprotein-I (beta 2GPI), a cofactor for antiphospholipid antibody (aPA) binding, binds to many anionic macromolecules including heparin. The nature of this interaction with heparin is not well understood and its effect on the purported biological functions of beta 2GPI is unknown.
T, McNally   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy